Patents by Inventor Vincent SOL

Vincent SOL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250040542
    Abstract: The invention relates to the field of selective herbicides and more specifically to the use of phenylphenalenones of formula (1) as a selective herbicide. The invention also relates to herbicidal compositions and to a method for selective weed control.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 6, 2025
    Inventors: Mohamad ISSAOUI, Catherine RIOU, Holm AMARA, Jérémy GODARD, Frédérique BREGIER, Vincent SOL
  • Publication number: 20240156098
    Abstract: The present invention relates to the use of cationic porphyrins such as zinc tetra(N-methylpyridyl)porphyrin tetrachloride and tetra(N-methylpyridyl)porphyrin tetrachloride or a mixture thereof, as selective foliar herbicidal agent.
    Type: Application
    Filed: February 17, 2022
    Publication date: May 16, 2024
    Inventors: Mohamad ISSAOUI, Catherine RIOU, Vincent SOL
  • Publication number: 20230241142
    Abstract: The invention relates to a dermatological composition comprising at least one polar extract of an alga of the Skeletonema genus or a photosensitizer derived therefrom, for the treatment of acne or bacterial infections; as well as a process for decontaminating a surface using a polar extract of an alga of the Skeletonema genus or a photosensitizer derived therefrom.
    Type: Application
    Filed: April 13, 2021
    Publication date: August 3, 2023
    Inventors: Jean-Baptiste BERARD, Louise LEFOULON, Laurent PICOT, Tan-Sothea OUK, Naïma SAAD, Cornelia LANDOLT, Karine GRENIER, Vincent SOL
  • Publication number: 20220249391
    Abstract: Disclosed is a complex including: cellulose nanocrystals; at least one ?-cyclodextrin molecule; and at least one curcumin molecule, suitable for use in the treatment of any kind of peripheral neuropathies. Further disclosed is a pharmaceutical composition including at least the complex and at least one pharmaceutically acceptable excipient. Also disclosed is the use of the complex or the pharmaceutical composition, in particular in the form of a hydrogel, a subcutaneous implant, an implantable pump, an implanted biofunctionalized nerve conduit, to improve the treatment compliance, to allow an extended release of the complex and to obtain better pharmacokinetics.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 11, 2022
    Inventors: Martial CAILLAUD, Alexis DESMOULIÈRE, Fabrice BILLET, Franck STURTZ, Gautier Marck Arthur NDONG-NTOUTOUME, Vincent SOL, Robert GRANET